Alex Faje

Biochemical Control in Acromegaly With Multimodality Therapies: Outcomes From a Pituitary Center and Changes Over Time

Alireza Ghajar, Pamela S. Jones, Francisco J. Guarda et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 48 citations · Full text

Medicine, Endocrinology, Surgery +17

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

Leyre Zubiri, Gabriel E. Molina, Meghan J. Mooradian et al. · Journal for ImmunoTherapy of Cancer · 2021 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17

Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: A tsunami is coming, but are we ready?

Kerry L. Reynolds, Justine V. Cohen, Sienna Durbin et al. · Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Immunology, Oncology +16

Cost of inpatient admissions for immune-related adverse effects from immune checkpoint inhibitor therapy: A single center experience.

Jacqueline N. Chu, Jin Choi, Sassan Ostvar et al. · Journal of Clinical Oncology · 2018 · 10 citations

Pharmacy, Oncology, Pharmacoeconomics +17